{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T01:31:47Z","timestamp":1772155907266,"version":"3.50.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/inf.0b013e318292f7b1","type":"journal-article","created":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T10:24:07Z","timestamp":1364466247000},"page":"889-897","source":"Crossref","is-referenced-by-count":23,"title":["Antibody Persistence and Booster Vaccination of a Fully Liquid Hexavalent Vaccine Coadministered With Measles\/Mumps\/Rubella and Varicella Vaccines at 15\u201318 Months of Age in Healthy South African Infants"],"prefix":"10.1097","volume":"32","author":[{"given":"Shabir A.","family":"Madhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthonet","family":"Koen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare","family":"Cutland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Groome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Santos-Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20-20210202","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1586\/erv.11.72","article-title":"A DTaP-IPVPRP approximately T vaccine (Pentaxim): a review of 16 years clinical experience.","volume":"10","author":"Plotkin","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"R2-20-20210202","doi-asserted-by":"crossref","first-page":"126","DOI":"10.7196\/SAMJ.4401","article-title":"Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of age in infants in South Africa.","volume":"101","author":"Madhi","year":"2011","journal-title":"S Afr Med J"},{"key":"R4-20-20210202","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40272-013-0007-7","article-title":"DTaP-IPV-Hep B-Hib vaccine (Hexaxim): a review of its use in primary and booster vaccination.","volume":"15","author":"McCormack","year":"2013","journal-title":"Paediatr Drugs"},{"key":"R5-20-20210202","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0264-410X(96)00239-3","article-title":"Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity.","volume":"15","author":"Diminsky","year":"1997","journal-title":"Vaccine"},{"key":"R6-20-20210202","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.biochi.2010.04.014","article-title":"Characterization of the lipid and protein organization in HBsAg viral particles by steady-state and time-resolved fluorescence spectroscopy.","volume":"92","author":"Greiner","year":"2010","journal-title":"Biochimie"},{"key":"R7-20-20210202","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.biochi.2010.09.018","article-title":"Nanoscale topography of hepatitis B antigen particles by atomic force microscopy.","volume":"93","author":"Milhiet","year":"2011","journal-title":"Biochimie"},{"key":"R8-20-20210202","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1016\/j.vaccine.2010.02.049","article-title":"Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10-45 years.","volume":"28","author":"Tregnaghi","year":"2010","journal-title":"Vaccine"},{"key":"R9-20-20210202","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/j.ijid.2010.12.004","article-title":"Immunogenicity and safety study of a new DTaP-IPV-Hep B-PRP-T combined vaccine compared to a licensed DTaP-IPV-Hep BPRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age in Thai infants.","volume":"15","author":"Kosalaraksa","year":"2011","journal-title":"Int J Infect Dis"},{"key":"R10-20-20210202","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1097\/INF.0b013e31820b93d2","article-title":"Immunogenicity and safety of an investigational fully liquid hexavalent combination vaccine versus licensed combination vaccines at 6, 10, and 14 weeks of age in healthy South African infants.","volume":"30","author":"Madhi","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R11-20-20210202","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1097\/INF.0b013e318212eb80","article-title":"Immunogenicity and safety of an investigational hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-hepatitis B-Haemophilus influenzae B conjugate combined vaccine in healthy 2-, 4-, and 6-month-old Argentinean infants.","volume":"30","author":"Tregnaghi","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R12-20-20210202","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1016\/j.vaccine.2012.07.040","article-title":"A fully liquid DTaP-IPV-Hep B-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Mexican children.","volume":"30","author":"Becerra","year":"2012","journal-title":"Vaccine"},{"key":"R13-20-20210202","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4172\/2157-7560.1000128","article-title":"Immunogenicity and safety of a fully liquid DTaP-IPV-Hep B-PRP-T vaccine at 2-4-6 months of age in Peru.","volume":"3","author":"Lanata","year":"2012","journal-title":"J Vaccines Vaccin"},{"key":"R17-20-20210202","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination.","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R18-20-20210202","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-sided confidence intervals for the single proportion: comparison of seven methods.","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"R19-20-20210202","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/INF.0b013e318242460a","article-title":"Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPVPRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPVPRP-T booster vaccination at 18 months of age in healthy Argentinean infants.","volume":"31","author":"Tregnaghi","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R20-20-20210202","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.vaccine.2005.08.058","article-title":"Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination.","volume":"24","author":"Bauer","year":"2006","journal-title":"Vaccine"},{"key":"R21-20-20210202","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.1016\/j.vaccine.2012.06.078","article-title":"Challenge with a hepatitis B vaccine in two cohorts of 4-7-year-old children primed with hexavalent vaccines: an open-label, randomised trial in Italy.","volume":"30","author":"Zanetti","year":"2012","journal-title":"Vaccine"},{"key":"R24-20-20210202","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/adc.2007.126888","article-title":"Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign.","volume":"93","author":"Ladhani","year":"2008","journal-title":"Arch Dis Child"},{"key":"R25-20-20210202","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1469-0691.2009.02945.x","article-title":"Participants of the European Union Invasive Bacterial Infections Surveillance Network. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes.","volume":"16","author":"Ladhani","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R27-20-20210202","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1097\/INF.0b013e318259fc8a","article-title":"Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age.","volume":"31","author":"Blatter","year":"2012","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-900000000-98371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T02:04:01Z","timestamp":1618020241000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201308000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318292f7b1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717995538.793476069","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717995538.793475604","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717995538.793474231","asserted-by":"object"}]},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}